September 19, 2017 : DCMS #363

DISASTERS AVERTED — Near Miss Case Studies

Insulin for Life Answering Calls for Help

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Sood & Messer Part 5, Methodology of Diabetic Treatment

HOMERUN SLIDES — Great Clinical Presentation Highlights

Albuminuria: A Lot More Than Just a Little Protein in the Urine Part 5

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #91: Lipid and Lipoprotein Metabolism, Hypolipidemic Agents, and Therapeutic Goals Part 3

MOST POPULAR ARTICLES OF THE MONTH

#1 Nonnutritive Sweeteners Linked To Weight Gain
#2 Type 1 Cured in Mice
#3 A New Perspective On Metformin Therapy In Type 1 Diabetes

On most Saturday mornings I go out at 8 AM with our local bike club for a 30 to 40 mile ride. I usually wake up about 6 AM, and will turn on my local NPR station and tune into the People’s Pharmacy. Joe and Terry Graedon have been hosting the show for more years than Steve and I have spent at Diabetes in Control. They provide real information on a multitude of topics concerning health, and not only do they talk about drugs, they also include many natural remedies. One of the things that makes their program unique, is the researchers and medical professionals that help them explain disease states, and complementary therapies.

Last week they had Marie-Pierre St-Onge, PhD, FAHA, Associate Professor of Nutritional Medicine at Columbia
University, join them to discuss the new AHA Scientific guidelines on meal timing and how it affects many things including cholesterol. During the chat she spoke about using medications to lower LDL and how foods that were previously taboo are now acceptable. This ties in perfectly with this week’s Clinical Gem on Lipid and Lipoprotein Metabolism, Hypolipidemic Agents, and Therapeutic Goals.

Dave Joffe

Editor-in-chief

Concerned about the extreme weather disasters we have had and those predicted, I reached out to Carol Atkinson, Director of Insulin for Life, a trusted organization, to see how we could help.

She was so busy putting packages together for people who have diabetes, she quickly told me the story of Wharton, Texas.

It was Labor Day weekend. Hurricane Harvey had just hit and it hit Wharton, Texas hard. They were in need of insulin.

Drs. Sood and Meeser talk with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the treatment methods that have brought them the most success for their patients.

In this week’s Homerun Slides, health conditions potentially indicated by albuminuria levels.

In the fasting state, hepatic VLDL assembly and secretion predominate. Utilization of nascent apo B100 for the assembly and secretion of VLDL is, to a large extent, limited by substrate availability, namely TG, as apo B100 is constitutively synthesized. In the presence of adequate TG, apo B100 is progressively lipidated through the actions of hepatic MTP, and the newly assembled VLDL particle is transported to the Golgi apparatus, where it may undergo further lipidation before secretion into plasma.

The evolution of metformin therapy through the decades.

Artificial sweeteners may offer short-term weight loss, but at what cost?

Ralph DeFronzo and his researchers at UT Health at San Antonio announced that they have cured type 1 diabetes.